Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues

Investigating and Resolving Cardiotoxicity Induced by COVID‐19 Treatments using Human Pluripotent Stem Cell‐Derived Cardiomyocytes and Engineered Heart Tissues

Abstract Coronavirus disease 2019 continues to spread worldwide. Given the urgent need for effective treatments, many clinical trials are ongoing through repurposing approved drugs. However, clinical data regarding the cardiotoxicity of these drugs are limited. Human pluripotent stem cell‐derived ca...

Full description

Bibliographic Details
Main Authors:	He Xu, Ge Liu, Jixing Gong, Ying Zhang, Shanshan Gu, Zhongjun Wan, Pengcheng Yang, Yage Nie, Yinghan Wang, Zhan‐peng Huang, Guanzheng Luo, Zhongyan Chen, Donghui Zhang, Nan Cao
Format:	Article
Language:	English
Published:	Wiley 2022-10-01
Series:	Advanced Science
Subjects:	cardiotoxicity engineered heart tissue high throughput screening human pluripotent stem cell‐derived cardiomyocytes repurposed drugs for COVID‐19
Online Access:	https://doi.org/10.1002/advs.202203388

Similar Items

Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes
by: Lu Cao, et al.
Published: (2020-05-01)

Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs)
by: Akshay Narkar, et al.
Published: (2022-03-01)

Molecular Mechanisms of Cardiomyocyte Death in Drug-Induced Cardiotoxicity
by: Wanjun Ma, et al.
Published: (2020-06-01)

An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes
by: Wesley L. McKeithan, et al.
Published: (2017-10-01)

Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
by: De-Shu Chen, et al.
Published: (2022-02-01)

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
by: Marco Bruno Morelli, et al.
Published: (2022-04-01)

Directed Differentiation of Zebrafish Pluripotent Embryonic Cells to Functional Cardiomyocytes
by: Yao Xiao, et al.
Published: (2016-09-01)

Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes
by: Francis Grafton, et al.
Published: (2021-08-01)

Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells
by: Xiaoqian Zhang, et al.
Published: (2017-04-01)

Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
by: Agapios Sachinidis
Published: (2020-04-01)

Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
by: Bin Bin Wu, et al.
Published: (2022-02-01)

Fatty Acid-Treated Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes Exhibit Adult Cardiomyocyte-Like Energy Metabolism Phenotypes
by: Yuichi Horikoshi, et al.
Published: (2019-09-01)

Carfilzomib Treatment Causes Molecular and Functional Alterations of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
by: Parvin Forghani, et al.
Published: (2021-12-01)

Modelling Metabolic Shifts during Cardiomyocyte Differentiation, Iron Deficiency and Transferrin Rescue Using Human Pluripotent Stem Cells
by: Benjamin B. Johnson, et al.
Published: (2021-12-01)

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
by: Sho Tanosaki, et al.
Published: (2021-02-01)

Induced pluripotent stem cells differentiation into cardiomyocytes by rotating suspension culture and in specific plates with microwells
by: G. Budash, et al.
Published: (2016-11-01)

Qualitative transcriptional signatures for evaluating the maturity degree of pluripotent stem cell-derived cardiomyocytes
by: Rou Chen, et al.
Published: (2019-03-01)

Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes
by: Xin Jiang, et al.
Published: (2020-07-01)

Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation
by: Susanne Rehnelt, et al.
Published: (2017-12-01)

Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes
by: Christina Schmid, et al.
Published: (2021-11-01)

Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
by: Minh Nguyen Tuyet Le, et al.
Published: (2019-05-01)

Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction
by: Yang Xiao, et al.
Published: (2022-08-01)

Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
by: Hao Yang, et al.
Published: (2023-08-01)

Generation of Functional Cardiomyocytes from Human Gastric Fibroblast-Derived Induced Pluripotent Stem Cells
by: Chih-Hsien Wu, et al.
Published: (2021-10-01)

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy
by: Yun-Gwi Park, et al.
Published: (2022-06-01)

In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts
by: Shin Kadota, et al.
Published: (2017-02-01)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
by: Maaike eHoekstra, et al.
Published: (2012-08-01)

Xenogeneic-Free System for Biomanufacturing of Cardiomyocyte Progeny From Human Pluripotent Stem Cells
by: Preeti Ashok, et al.
Published: (2020-10-01)

Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure
by: Songyan Liao, et al.
Published: (2019-03-01)

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs
by: Ignacio Reinal, et al.
Published: (2023-07-01)

Protective effects of protocatechuic acid against doxorubicin- and arsenic trioxide-induced toxicity in cardiomyocytes
by: Shafiee Fatemeh, et al.
Published: (2023-01-01)

Spontaneous recovery from sunitinib-induced disruption of sarcomere in human iPSC-cardiomyocytes and possible involvement of the Hippo pathway
by: Toshikatsu Matsui, et al.
Published: (2021-10-01)

Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
by: Emma Claire James, et al.
Published: (2021-03-01)

Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells
by: Yong-Jin Kim, et al.
Published: (2021-08-01)

Evaluation of the cardiotoxicity potential of bisphenol analogues in human induced pluripotent stem cells derived cardiomyocytes
by: Seul-Gi Lee, et al.
Published: (2024-03-01)

Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes
by: Marzia De Bortoli, et al.
Published: (2023-01-01)

Three-dimensional cardiac organoid formation accelerates the functional maturation of human induced pluripotent stem cell-derived cardiomyocytes
by: Hanbyeol Lee, et al.
Published: (2022-05-01)

Three-Dimensional Poly-(ε-Caprolactone) Nanofibrous Scaffolds Promote the Maturation of Human Pluripotent Stem Cells-Induced Cardiomyocytes
by: Mingming Zhang, et al.
Published: (2022-08-01)

Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
by: Jiangtao Li, et al.
Published: (2022-06-01)

Approaches to High-Throughput Analysis of Cardiomyocyte Contractility
by: Peter T. Wright, et al.
Published: (2020-07-01)